Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe

Farmaco

Volumn 55, Issue 4, 2000, Pages 308-313

  Pagani Zecchini, Giampiero ^a   Paglialunga Paradisi, Mario ^a   Torrini, Ines ^a   Nalli, Marianna ^a   Lucente, Gino ^a   Spisani, Susanna ^b  

^a CNR   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biscarbamates; Carbamates; Chemotactic peptides; Human neutrophils

Indexed keywords

BISCARBAMATE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; STRUCTURE ACTIVITY RELATION;

CARBAMATES; CHEMOTACTIC FACTORS; HUMANS; MOLECULAR STRUCTURE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEPTIDES;

EID: 0033841484     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(00)00045-8     Document Type: Article

References (21)

1. Marasco W.A., Phan S.H., Krutzsch H., Showell H.J., Feltner D.E., Nairn R., Becker E.L., Ward P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:1984;5430-5439.
2. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155:1982;264-275.
3. Becker E.L., Bleich H.E., Day A.R., Freer R.J., Glasel J.A., Visintainer J. Nuclear magnetic resonance conformational studies on the chemotactic tripeptide formyl-L-methionyl-L-leucyl-L-phenylalanine. A small β sheet. Biochemistry. 18:1979;4656-4668.
4. Williams L.T., Snyderman R., Pike M.C., Lefkowitz R.J. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA. 74:1977;1204-1208.
5. Boulay F., Tardif M., Brouchon L., Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 29:1990;11123-11133.
6. Freer R.J., Day A.R., Radding J.A., Schiffmann E., Aswanikumar S., Showell H.J., Becker E.L. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry. 19:1980;2404-2410.
7. Gavuzzo E., Lucente G., Mazza F., Pagani Zecchini G., Paglialunga Paradisi M., Pochetti G., Torrini I. Structural modification and conformational features of chemotactic N-formylpeptides. Curr. Top. Peptide Prot. Res. 1:1994;275-295.
8. Gao J.-L., Becker E.L., Freer R.J., Muthukumaraswamy N., Murphy P.M. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J. Exp. Med. 180:1994;2191-2197.
9. Derian C.K., Solomon H.F., Higgins J.D. III, Beblavy M.J., Santulli R.J., Bridger G.J., Pike M.C., Kroon D.J., Fischman A.J. Biochemistry. 35:1996;1265-1269.
10. Higgins J.D. III, Bridger G.J., Derian C.K., Beblavy M.J., Hernandez P.E., Gaul F.E., Abrams M.J., Pike M.C., Solomon H.F. N-Terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 39:1996;1013-1015.
11. Fruchtmann R., Kreisfeld K., Marowski C., Opitz W. Synthetische tripeptide als chemotaxine bzw. chemotaxinanantagonisten. Hoppe-Seyler's Z. Physiol. Chem. 362:1981;163-174.
12. Opitz W., Fruchtmann R. Acylierte tripeptide als chemotaxinanantagonisten. Hoppe-Seyler's Z. Physiol. Chem. 362:1981;1037-1041.
13. Pagani Zecchini G., Paglialunga Paradisi M., Torrini I., Spisani S. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives. Arch. Pharm. (Weinheim). 328:1995;673-676.
14. Torrini I., Paglialunga Paradisi M., Pagani Zecchini G., Lucente G., Gavuzzo E., Mazza F., Pochetti G., Traniello S., Spisani S. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2′-(methylthio)ethyl]methionine residue. Biopolymers. 42:1997;415-426.
15. Pagani Zecchini G., Torrini I., Paglialunga Paradisi M., Lucente G., Mastropietro G., Spisani S. Modified chemotactic peptides: synthesis and activity of an azaTic-containing fMLP-OMe analogue. Amino Acids. 14:1998;301-309.
16. Torrini I., Mastropietro G., Pagani Zecchini G., Paglialunga Paradisi M., Lucente G., Spisani S. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue. Arch. Pharm. Pharm. Med. Chem. 331:1998;170-176.
17. Freer R.J., Day A.R., Muthukumaraswamy N., Pinon D., Wu A., Showell H.J., Becker E.L. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. Biochemistry. 21:1982;257-263.
18. Boger J., Payne L.S., Perlow D.S., Lohr N.S., Poe M., Blaine E.H., Ulm E.H., Schorn T.W., LaMont B.I., Lin T.-Y., Kawai M., Rich D.H., Veber D.F. Renine inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. J. Med. Chem. 28:1985;1779-1790.
19. Vertuani G., Spisani S., Boggian M., Traniello S., Scatturin A. Conformational studies of synthetic tripeptide chemoattractants. Int. J. Peptide Protein Res. 29:1987;525-532.
20. Huang X., Keillor J.W. Preparation of methyl carbamates via a modified Hofmann rearrangement. Tetrahedron Lett. 38:1997;313-316.
21. Zigmond S.H., Hirsch J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-derived chemotactic factor. J. Exp. Med. 137:1973;387-410.